Joseph Stringer Analyst PerformanceSenior Analyst at Needham & Company LLCJoseph Stringer is a stock analyst at Needham & Company LLC in the healthcare sector, covering 19 publicly traded companies. Over the past year, Joseph Stringer has issued 39 stock ratings, including buy and hold recommendations. While full access to Joseph Stringer's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Joseph Stringer's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings114 Last 5 YearsBuy Recommendations87.72% 100 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution114RatingsDistribution of strong buy, buy, hold, and sell ratings by Joseph Stringer.RatingPercentageCount Strong Buy0.0%0 ratings Buy87.7%100 ratings Hold12.3%14 ratings Sell0.0%0 ratingsOut of 114 total stock ratings issued by Joseph Stringer at Needham & Company LLC, the majority (87.7%) have been Buy recommendations, followed by 12.3% Hold.Best & Worst CallsBest Call0000.0%STOKApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%PLRXFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ19 companiesJoseph Stringer, an analyst at Needham & Company LLC, currently covers 19 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare19 companies100.0%Joseph Stringer of Needham & Company LLC specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY16 companies84.2%PHARMACEUTICALS3 companies15.8% About Joseph StringerJoseph Stringer joined Needham & Company in 2017, where he covers biotechnology companies. Prior to Needham, Joseph worked as a research scientist at Ra Pharmaceuticals. He conducted postdoctoral work at Yale University, earned his Ph.D. in Chemistry from the University of Wisconsin – Madison, and received a B.S. in Chemistry from Southern Illinois University – Carbondale.Follow on LinkedIn Joseph Stringer's Ratings History at Needham & Company LLC Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsBIOABioAge Labs7/31/2026Lower Price Target$8.96$35.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals7/30/2026Lower Price Target$201.88$357.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals7/30/2026Lower Price Target$8.90$22.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals7/28/2026Reiterated Rating$41.03$83.00Buy$0.0000.00% ROIANNXAnnexon7/15/2026Boost Price Target$5.55$25.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals7/9/2026Lower Price Target$64.56$86.00Buy$0.0000.00% ROISTTKShattuck Labs6/8/2026Boost Price Target$3.83$17.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals3/31/2026Downgrade$40.27Hold$0.0000.00% ROIBIOABioAge Labs3/27/2026Initiated Coverage$16.25$50.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals3/25/2026Boost Price Target$73.16$105.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. STOKStoke Therapeutics3/17/2026Boost Price Target$33.96$40.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals3/17/2026Lower Price Target$90.51$130.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals2/26/2026Lower Price Target$98.07$139.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals2/25/2026Boost Price Target$81.09$103.00Buy$0.0000.00% ROIVIRVir Biotechnology2/24/2026Boost Price Target$7.43$18.00Buy$0.0000.00% ROIGILDGilead Sciences2/23/2026Reiterated Rating$149.74$170.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals2/12/2026Lower Price Target$309.64$510.00Buy$0.0000.00% ROIGILDGilead Sciences2/11/2026Boost Price Target$147.23$170.00Buy$0.0000.00% ROIVIRVir Biotechnology2/9/2026Reiterated Rating$7.19$14.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals1/13/2026Lower Price Target$23.20$28.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals1/12/2026Boost Price Target$398.29$529.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals1/9/2026Boost Price Target$101.53$148.00Buy$0.0000.00% ROIPCVXVaxcyte1/7/2026Boost Price Target$44.85$110.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals12/11/2025Boost Price Target$119.00$145.00Buy$0.0000.00% ROICDTXCidara Therapeutics11/14/2025Downgrade$217.79Hold$0.0000.00% ROIGILDGilead Sciences11/13/2025Boost Price Target$126.57$140.00Buy$0.0000.00% ROICDTXCidara Therapeutics11/7/2025Boost Price Target$98.64$135.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals11/4/2025Boost Price Target$107.17$122.00Buy$0.0000.00% ROIGILDGilead Sciences10/31/2025Reiterated Rating$118.44$133.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals10/30/2025Boost Price Target$71.88$90.00Buy$0.0000.00% ROIRNAAvidity Biosciences10/27/2025Downgrade$49.15$65.00Hold$0.0000.00% ROIMRNAModerna10/20/2025Reiterated Rating$26.01Hold$0.0000.00% ROISTOKStoke Therapeutics10/10/2025Boost Price Target$29.90$35.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals10/8/2025Boost Price Target$71.12$78.00Buy$0.0000.00% ROICDTXCidara Therapeutics9/24/2025Boost Price Target$87.51$100.00Buy$0.0000.00% ROIRNAAvidity Biosciences9/10/2025Boost Price Target$46.98$65.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals9/2/2025Boost Price Target$56.47$70.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals8/25/2025Reiterated Rating$42.69$55.00Buy$0.0000.00% ROICDTXCidara Therapeutics8/8/2025Reiterated Rating$61.73$74.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals7/31/2025Boost Price Target$393.00$478.00Buy$000.0000.00% ROIPorter flew 3,300 miles to investigate this system (Ad)Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.Watch the full investigation and decide for yourselfGILDGilead Sciences7/25/2025Upgrade$113.20$133.00Buy$000.0000.00% ROIRYTMRhythm Pharmaceuticals7/9/2025Reiterated Rating$85.44$95.00Buy$000.0000.00% ROISTOKStoke Therapeutics7/1/2025Reiterated Rating$11.35$22.00Buy$00.0000.00% ROIALNYAlnylam Pharmaceuticals6/26/2025Boost Price Target$321.94$377.00Buy$000.0000.00% ROICDTXCidara Therapeutics6/23/2025Boost Price Target$40.74$54.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals6/6/2025Reiterated Rating$9.58$28.00Buy$00.0000.00% ROICDTXCidara Therapeutics6/4/2025Boost Price Target$23.30$36.00Buy$0.0000.00% ROICDTXCidara Therapeutics5/23/2025Reiterated Rating$25.70$35.00Buy$0.0000.00% ROIVIRVir Biotechnology5/22/2025Reiterated Rating$4.51$14.00Buy$0.0000.00% ROIGILDGilead Sciences5/21/2025Reiterated Rating$109.11Hold$000.0000.00% ROIANNXAnnexon5/13/2025Lower Price Target$1.77$11.00Buy$0.0000.00% ROIVIRVir Biotechnology5/12/2025Lower Price Target$5.40$14.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals5/7/2025Lower Price Target$17.78$29.00Buy$00.0000.00% ROIRYTMRhythm Pharmaceuticals5/7/2025Boost Price Target$64.90$72.00Buy$00.0000.00% ROIVRTXVertex Pharmaceuticals5/6/2025Reiterated Rating$500.19Hold$000.0000.00% ROIIONSIonis Pharmaceuticals4/30/2025Lower Price Target$30.84$55.00Buy$00.0000.00% ROIGILDGilead Sciences4/25/2025Reiterated Rating$106.15Hold$000.0000.00% ROIPHATPhathom Pharmaceuticals4/21/2025Reiterated Rating$4.03$28.00Buy$00.0000.00% ROIIONSIonis Pharmaceuticals4/15/2025Reiterated Rating$28.68$60.00Buy$00.0000.00% ROICDTXCidara Therapeutics4/10/2025Reiterated Rating$17.47$35.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals4/9/2025Reiterated Rating$224.32$320.00Buy$000.0000.00% ROIPHATPhathom Pharmaceuticals4/9/2025Reiterated Rating$4.25$28.00Buy$00.0000.00% ROISTOKStoke Therapeutics4/9/2025Reiterated Rating$5.90$22.00Buy$00.0000.00% ROIRNAAvidity Biosciences4/9/2025Reiterated Rating$24.08$60.00Buy$00.0000.00% ROIRYTMRhythm Pharmaceuticals4/8/2025Reiterated Rating$54.96$66.00Buy$00.0000.00% ROIPCVXVaxcyte4/8/2025Reiterated Rating$32.51$90.00Buy$00.0000.00% ROIIONSIonis Pharmaceuticals4/8/2025Reiterated Rating$27.57$60.00Buy$00.0000.00% ROIPHATPhathom Pharmaceuticals4/2/2025Reiterated Rating$5.12$28.00Buy$00.0000.00% ROIPCVXVaxcyte4/1/2025Lower Price Target$37.76$90.00Buy$00.0000.00% ROIALNYAlnylam Pharmaceuticals3/21/2025Reiterated Rating$253.60$320.00Buy$000.0000.00% ROIRYTMRhythm Pharmaceuticals3/18/2025Boost Price Target$52.34$66.00Buy$00.0000.00% ROISTOKStoke Therapeutics3/18/2025Reiterated Rating$8.67$22.00Buy$00.0000.00% ROIRNAAvidity Biosciences3/17/2025Reiterated Rating$32.78$60.00Buy$00.0000.00% ROICDTXCidara Therapeutics3/7/2025Reiterated Rating$23.61$35.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals3/6/2025Reiterated Rating$5.67$28.00Buy$00.0000.00% ROIANNXAnnexon3/4/2025Reiterated Rating$2.39$16.00Buy$0.0000.00% ROIPLRXPliant Therapeutics3/4/2025Reiterated Rating$1.38$10.00Hold$0.0000.00% ROILXRXLexicon Pharmaceuticals3/3/2025Reiterated Rating$0.35Hold$0.0000.00% ROIVIRVir Biotechnology2/27/2025Reiterated Rating$9.20$19.00Buy$0.0000.00% ROIRYTMRhythm Pharmaceuticals2/27/2025Reiterated Rating$53.32$64.00Buy$00.0000.00% ROIPCVXVaxcyte2/26/2025Reiterated Rating$79.35$140.00Buy$00.0000.00% ROIALNYAlnylam Pharmaceuticals2/26/2025Reiterated Rating$245.20$320.00Buy$000.0000.00% ROIIONSIonis Pharmaceuticals2/20/2025Reiterated Rating$31.81$60.00Buy$00.0000.00% ROIRYTMRhythm Pharmaceuticals2/19/2025Reiterated Rating$57.55$64.00Buy$000.0000.00% ROISTOKStoke Therapeutics2/18/2025Reiterated Rating$9.74$22.00Buy$00.0000.00% ROIALNYAlnylam Pharmaceuticals2/14/2025Reiterated Rating$264.89$320.00Buy$000.0000.00% ROIGILDGilead Sciences2/12/2025Reiterated Rating$96.14Hold$000.0000.00% ROIPCVXVaxcyte2/11/2025Reiterated Rating$85.94$14.00Buy$00.0000.00% ROIVRTXVertex Pharmaceuticals2/11/2025Reiterated Rating$469.97Hold$000.0000.00% ROIPLRXPliant Therapeutics2/10/2025Lower Price Target$7.79$10.00Buy$0.0000.00% ROIYour book attached (Ad)Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.Download the Safe Trade Options Formula book for free before access closesVRTXVertex Pharmaceuticals1/31/2025Reiterated Rating$438.40Hold$000.0000.00% ROILXRXLexicon Pharmaceuticals1/29/2025Reiterated Rating$0.93Hold$0.0000.00% ROIALNYAlnylam Pharmaceuticals1/13/2025Reiterated Rating$237.98$320.00Buy$000.0000.00% ROIPHATPhathom Pharmaceuticals1/10/2025Reiterated Rating$6.95$28.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupUBS GroupThe Goldman Sachs GroupWeiss RatingsCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.TD CowenTruist FinancialPiper SandlerDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
